Back

Answers in CME Inc. (AiCME)

  • alpha 1-Antitrypsin Deficiency

From Screening to Specialized Care: Navigating Key Questions in AATD-Associated Liver Disease

This enduring education aims to improve clinicians ability to use current best practices for screening, diagnosis, and assessment of AATD-associated liver disease to improve patient outcomes. As a result of this educational activity, learners will be better able to: 1. Apply strategies to reach a diagnosis of AATD and associated liver disease; 2. Summarize the evolving treatment landscape for AATD-associated liver disease; and, 3. Explain multidisciplinary team approaches to effectively manage patients with AATD-associated liver disease. Learners have access to downloadable materials and podcast for future use in practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • includes Podcast / audio
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Mar 13, 2026
  • Last day to claim credit
    Mar 13, 2027 5 months left